co.don AG EV/EBITDA
What is the EV/EBITDA of co.don AG?
The EV/EBITDA of co.don AG is N/A
What is the definition of EV/EBITDA?
EV/EBITDA is enterprise value divided by earnings before interest, tax, depreciation, and amortization. It is a measure of how expensive a stock is and is more frequently valid for comparisons across companies than the price to earnings ratio. It measures the price (in the form of enterprise value) an investor pays for the benefit of the company’s cash flow (in the form of EBITDA).
= enterprise value / EBITDA
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
EV/EBITDA of companies in the Health Care sector on XETRA compared to co.don AG
What does co.don AG do?
co.don AG engages in cell cultivation for the regenerative treatment of articular cartilage and spinal disc defects worldwide. The company develops, produces, and markets autologous cell therapies for the minimally invasive repair of cartilage damage to knee joints following traumatic or degenerative defects. Its therapies include matrix-associated autologous cartilage transplantation, a biological therapy for the treatment of damaged articular cartilage with the body's own cells; and autologous chondrocyte transplantation for the regeneration of biomechanical load-bearing and pressure-resistant cartilage tissue. co.don AG was founded in 1993 and is headquartered in Teltow, Germany.
Companies with ev/ebitda similar to co.don AG
- Metalex Ventures has EV/EBITDA of N/A
- Minfocus Exploration has EV/EBITDA of N/A
- Advance Gold has EV/EBITDA of N/A
- Rincon Resources has EV/EBITDA of N/A
- Argent Minerals has EV/EBITDA of N/A
- Protokinetix has EV/EBITDA of N/A
- co.don AG has EV/EBITDA of N/A
- Central Timmins Exploration has EV/EBITDA of N/A
- Kin Pang has EV/EBITDA of N/A
- Bossini International has EV/EBITDA of N/A
- Ecofibre has EV/EBITDA of N/A
- e Actiplay SA has EV/EBITDA of N/A
- Fox Marble PLC has EV/EBITDA of N/A